Zepp Health Corporation
Zepp Health Corporation (ZEPP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
zepp · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Zepp Health Corporation (ZEPP) measures how much investors pay for each dollar of the company's trailing earnings. ZEPP's current PE ratio of N/A is calculated by dividing its stock price of $6.18 by its TTM earnings per share of -$289.80.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 6 fiscal years · Front-end computedMinQ1 · 25%18.5x
MedianQ3 · 75%185.3x
Max
At N/A, ZEPP's current P/E is lower than in 0% of its annual fiscal year readings over the past 6 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Consumer Electronics · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Zepp Health CorporationYou ZEPP | $89M | N/A | — | -$289.80 |
 Arrive AI Inc. ARAI | $16M | N/A | — | -$0.40 |
 Babcock & Wilcox Enterprises, Inc. BW | $1.8B | N/A | — | -$0.34 |
 Expensify, Inc. EXFY | $114M | N/A | — | -$0.23 |
 KULR Technology Group, Inc. KULR | $173M | N/A | — | -$1.56 |
 Stem, Inc. STEM | $70M | 0.91x | — | $16.52 |
 Silvaco Group, Inc. Common Stock SVCO | $376M | N/A | — | -$1.39 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-282.65 | — | |
2024-12-31 FY2024 | — | $-34.25 | — | |
2023-12-31 FY2023 | — | $-14.51 | — | |
2022-12-31 FY2022 | — | $-19.06 | — | |
2021-12-31 FY2021 | 14.87x | $8.63 | -33.1% | |
2020-12-31 FY2020 | 22.21x | $13.93 | +147.1% | |
2019-12-31 FY2019 | 8.99x | $37.24 | -16.0% | |
2018-12-31 FY2018 | 10.70x | $25.26 | -59.8% | |
2017-12-31 FY2017 | 26.61x | $11.00 | -85.6% | |
2016-12-31 FY2016 | 185.33x | $1.69 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Zepp Health Corporation (ZEPP) measures how much investors pay for each dollar of the company's trailing earnings. ZEPP's current PE ratio of N/A is calculated by dividing its stock price of $6.18 by its TTM earnings per share of -$289.80.
Frequently asked questions
ZEPP pe ratio · 6 questionsZEPP's current PE ratio is N/A as of 2026-06-08, based on a stock price of $6.18 and TTM EPS of -$289.80. Data sourced from Financial Modeling Prep via ZEPP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Zepp Health Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08